Fungal infection: diagnosis and management
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Format: | Buch |
| Sprache: | English |
| Veröffentlicht: |
Oxford [u.a.]
Blackwell Science
1997
|
| Ausgabe: | 2. ed. |
| Schlagworte: | |
| Online-Zugang: | Inhaltsverzeichnis |
| Beschreibung: | XXI, 249 S. |
| ISBN: | 0865427240 |
Internformat
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV011840525 | ||
| 003 | DE-604 | ||
| 005 | 20160429 | ||
| 007 | t | ||
| 008 | 980319s1997 |||| 00||| eng d | ||
| 020 | |a 0865427240 |9 0-86542-724-0 | ||
| 035 | |a (OCoLC)36430944 | ||
| 035 | |a (DE-599)BVBBV011840525 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-19 | ||
| 050 | 0 | |a RC117 | |
| 082 | 0 | |a 616.9/69 |2 21 | |
| 100 | 1 | |a Richardson, Malcolm D. |e Verfasser |0 (DE-588)139003142 |4 aut | |
| 245 | 1 | 0 | |a Fungal infection |b diagnosis and management |c Malcolm D. Richardson ; David W. Warnock |
| 250 | |a 2. ed. | ||
| 264 | 1 | |a Oxford [u.a.] |b Blackwell Science |c 1997 | |
| 300 | |a XXI, 249 S. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 650 | 4 | |a Mycoses | |
| 650 | 4 | |a Mycoses |x diagnosis | |
| 650 | 4 | |a Mycoses |x therapy | |
| 650 | 0 | 7 | |a Therapie |0 (DE-588)4059798-2 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Mykose |0 (DE-588)4075152-1 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Diagnose |0 (DE-588)4012040-5 |2 gnd |9 rswk-swf |
| 689 | 0 | 0 | |a Mykose |0 (DE-588)4075152-1 |D s |
| 689 | 0 | 1 | |a Diagnose |0 (DE-588)4012040-5 |D s |
| 689 | 0 | |8 1\p |5 DE-604 | |
| 689 | 1 | 0 | |a Mykose |0 (DE-588)4075152-1 |D s |
| 689 | 1 | 1 | |a Therapie |0 (DE-588)4059798-2 |D s |
| 689 | 1 | |8 2\p |5 DE-604 | |
| 700 | 1 | |a Warnock, David W. |e Verfasser |0 (DE-588)172443059 |4 aut | |
| 856 | 4 | 2 | |m HBZ Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=007996428&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-007996428 | ||
| 883 | 1 | |8 1\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
| 883 | 1 | |8 2\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
Datensatz im Suchindex
| _version_ | 1804126383878701056 |
|---|---|
| adam_text | Contents
Preface to the second edition, xix
Preface to the first edition, xx
Acknowledgements, xxi
1 Introduction, 1
1.1 The nature of fungi, 1
1.2 Fungi as human pathogens, 2
1.2.1 The superficial mycoses, 3
1.2.2 The subcutaneous mycoses, 3
1.2.3 The systemic mycoses, 4
1.3 The changing pattern of fungal infection, 5
1.4 Implications for diagnosis and management, 7
2 Laboratory diagnosis of
fungal infection, 9
2.1 Introduction, 9
2.2 Collection of specimens, 10
2.2.1 Skin, nails and hair, 10
2.2.2 Mucous membranes, 11
2.2.3 Ear, 11
2.2.4 Eye, 12
2.2.5 Blood, 12
2.2.6 Cerebrospinal fluid, 13
2.2.7 Urine, 13
2.2.8 Other fluids, 13
2.2.9 Lower respiratory tract specimens, 13
2.2.10 Pus, 14
2.2.11 Bone marrow, 14
2.2.12 Tissue, 15
2.3 Specimens for serological tests, 15
2.4 Specimens for antifungal drug level determinations, 15
2.5 Transport of specimens, 15
2.6 Interpretation of laboratory test results, 16
2.6.1 Direct microscopic examination, 16
2.6.2 Culture, 17
2.6.3 Serological tests, 18
2.6.4 Histopathological examination, 18
3 Antifungal drugs, 20
3.1 Introduction, 20
V
Vl/CONTENTS 3.2 Amphotericin B, 20
3.2.1 Mechanism of action, 20
3.2.2 Spectrum of action, 21
3.2.3 Acquired resistance, 21
3.2.4 Pharmacokinetics, 21
3.2.5 Metabolism, 23
3.2.6 Pharmaceutics, 23
3.2.7 Therapeutic use, 24
3.2.8 Mode of administration, 25
3.2.9 Adverse reactions, 28
3.2.10 Drug interactions, 30
3.3 Fluconazole, 30
3.3.1 Mechanism of action, 30
3.3.2 Spectrum of action, 30
3.3.3 Acquired resistance, 31
3.3.4 Pharmacokinetics, 31
3.3.5 Metabolism, 32
3.3.6 Pharmaceutics, 32
3.3.7 Therapeutic use, 32
3.3.8 Mode of administration, 33
3.3.9 Adverse reactions, 34
3.3.10 Drug interactions, 34
3.4 Flucytosine, 35
3.4.1 Mechanism of action, 35
3.4.2 Spectrum of action, 35
3.4.3 Acquired resistance, 36
3.4.4 Pharmacokinetics, 36
3.4.5 Metabolism, 36
3.4.6 Pharmaceutics, 37
3.4.7 Therapeutic use, 37
3.4.8 Mode of administration, 37
3.4.9 Adverse reactions, 37
3.4.10 Drug interactions, 38
3.5 Griseofulvin, 38
3.5.1 Mechanism of action, 38
3.5.2 Spectrum of action, 39
3.5.3 Acquired resistance, 39
3.5.4 Pharmacokinetics, 39
3.5.5 Metabolism, 39
3.5.6 Pharmaceutics, 39
3.5.7 Therapeutic use, 39
3.5.8 Mode of administration, 40
3.5.9 Adverse reactions, 40
3.5.10 Drug interactions, 40
3.6 Itraconazole, 40
3.6.1 Mechanism of action, 40
3.6.2 Spectrum of action, 41
CONTENTS/vii
3.6.3 Acquired resistance, 41
3.6.4 Pharmacokinetics, 41
3.6.5 Metabolism, 42
3.6.6 Pharmaceutics, 42
3.6.7 Therapeutic use, 42
3.6.8 Mode of administration, 42
3.6.9 Adverse reactions, 43
3.6.10 Drug interactions, 44
3.7 Ketoconazole, 44
3.7.1 Mechanism of action, 45
3.7.2 Spectrum of action, 45
3.7.3 Acquired resistance, 45
3.7.4 Pharmacokinetics, 45
3.7.5 Metabolism, 45
3.7.6 Pharmaceutics, 45
3.7.7 Therapeutic use, 46
3.7.8 Mode of administration, 46
3.7.9 Adverse reactions, 46
3.7.10 Drug interactions, 47
3.8 Miconazole, 47
3.8.1 Mechanism of action, 47
3.8.2 Spectrum of action, 48
3.8.3 Acquired resistance, 48
3.8.4 Pharmacokinetics, 48
3.8.5 Metabolism, 48
3.8.6 Pharmaceutics, 48
3.8.7 Therapeutic use, 49
3.8.8 Mode of administration, 49
3.8.9 Adverse reactions, 49
3.8.10 Drug interactions, 50
3.9 Terbinafine, 50
3.9.1 Mechanism of action, 50
3.9.2 Spectrum of action, 50
3.9.3 Acquired resistance, 50
3.9.4 Pharmacokinetics, 50
3.9.5 Metabolism, 51
3.9.6 Pharmaceutics, 51
3.9.7 Therapeutic use, 51
3.9.8 Mode of administration, 51
3.9.9 Adverse reactions, 52
3.9.10 Drug interactions, 52
3.10 Other compounds for topical administration, 52
3.10.1 Amorolfine, 52
3.10.2 Bifonazole, 52
3.10.3 Clotrimazole, 52
3.10.4 Econazole nitrate, 53
3.10.5 Isoconazole nitrate, 53
viii/CONTENTS 3.10.6 Naftifine, 53
3.10.7 Natamycin, 53
3.10.8 Nystatin, 53
3.10.9 Sulconazole nitrate, 53
3.10.10 Tioconazole, 53
3.11 Empirical treatment of suspected fungal infection
in the neutropenic patient, 53
3.12 Prophylactic treatment for prevention of fungal
infection, 54
3.13 Laboratory monitoring, 55
3.13.1 Amphotericin B, 55
3.13.2 Fluconazole, 56
3.13.3 Flucytosine, 57
3.13.4 Itraconazole, 57
3.13.5 Ketoconazole, 58
4 Dermatophytosis, 59
4.1 Introduction, 59
4.2 The causal organisms and their habitat, 59
4.3 Laboratory diagnosis of dermatophytosis, 60
4.4 Tinea capitis, 61
4.4.1 Definition, 61
4.4.2 Geographical distribution, 61
4.4.3 Causal organisms, 61
4.4.4 Clinical manifestations, 62
4.4.5 Differential diagnosis, 63
4.4.6 Essential investigations and their
interpretation, 63
4.4.7 Management, 64
4.5 Tinea corporis, 65
4.5.1 Definition, 65
4.5.2 Geographical distribution, 65
4.5.3 Causal organisms, 65
4.5.4 Clinical manifestations, 65
4.5.5 Differential diagnosis, 66
4.5.6 Essential investigations and their
interpretation, 66
4.5.7 Management, 66
4.6 Tinea cruris, 67
4.6.1 Definition, 67
4.6.2 Geographical distribution, 67
4.6.3 Causal organisms, 67
4.6.4 Clinical manifestations, 67
4.6.5 Differential diagnosis, 68
4.6.6 Essential investigations and their
interpretation, 68
L#f , .„ 4 6.7 Management, 68
1^
CONTENTS/ix
4.7 Tinea pedis, 69
4.7.1 Definition, 69
4.7.2 Geographical distribution, 69
4.7.3 Causal organisms, 69
4.7.4 Clinical manifestations, 69
4.7.5 Differential diagnosis, 70
4.7.6 Essential investigations and their
interpretation, 71
4.7.7 Management, 71
4.8 Tinea manuum, 72
4.8.1 Definition, 72
4.8.2 Geographical distribution, 72
4.8.3 Causal organisms, 72
4.8.4 Clinical manifestations, 73
4.8.5 Differential diagnosis, 73
4.8.6 Essential investigations and their
interpretation, 74
4.8.7 Management, 74
4.9 Tinea unguium, 74
4.9.1 Definition, 74
4.9.2 Geographical distribution, 74
4.9.3 Causal organisms, 74
4.9.4 Clinical manifestations, 75
4.9.5 Differential diagnosis, 75
4.9.6 Essential investigations and their
interpretation, 76
4.9.7 Management, 77
5 Superficial candidosis, 78
5.1 Definition, 78
5.2 Geographical distribution, 78
5.3 The causal organisms and their habitat, 78
5.4 Clinical manifestations, 79
5.4.1 Oral candidosis, 79
5.4.2 Vaginal candidosis, 81
5.4.3 Penile candidosis, 82
5.4.4 Cutaneous candidosis, 83
5.4.5 Candida nail infection, 84
5.4.6 Chronic mucocutaneous candidosis, 85
5.5 Superficial candidosis in special hosts, 86
5.6 Essential investigations and their interpretation, 87
5.7 Management, 87
5.7.1 Oral candidosis, 87
5.7.2 Vaginal candidosis, 89
5.7.3 Penile candidosis, 91
5.7.4 Cutaneous candidosis, 92
5.7.5 Candida nail infection, 92
x/CONTENTS
5.7.6 Chronic mucocutaneous candidosis, 92
6 Other cutaneous fungal infections, 94
6.1 Pityriasis versicolor, 94
6.1.1 Definition, 94
6.1.2 Geographical distribution, 94
6.1.3 The causal organism and its habitat, 94
6.1.4 Clinical manifestations, 95
6.1.5 Differential diagnosis, 95
6.1.6 Essential investigations and their
interpretation, 96
6.1.7 Management, 96
6.2 Other Malassezia infections, 97
6.2.1 Malassezia folliculitis, 97
6.2.2 Seborrhoeic dermatitis, 97
6.3 Piedra, 98
6.4 White piedra, 98
6.4.1 Definition, 98
6.4.2 Geographical distribution, 98
6.4.3 The causal organism and its habitat, 99
6.4.4 Clinical manifestations, 99
6.4.5 Differential diagnosis, 99
6.4.6 Essential investigations and their
interpretation, 99
6.4.7 Management, 100
6.5 Black piedra, 100
6.5.1 Definition, 100
6.5.2 Geographical distribution, 100
6.5.3 The causal organism and its habitat, 100
6.5.4 Clinical manifestations, 100
6.5.5 Differential diagnosis, 101
6.5.6 Essential investigations and their
interpretation, 101
6.5.7 Management, 101
6.6 Tinea nigra, 101
6.6.1 Definition, 101
6.6.2 Geographical distribution, 101
6.6.3 The causal organism and its habitat, 101
6.6.4 Clinical manifestations, 102
6.6.5 Differential diagnosis, 102
6.6.6 Essential investigations and their
interpretation, 102
6.6.7 Management, 102
6.7 Scytalidium infection, 102
7 Mould infections of nails, 104
7.1 Definition, 104
r,Jk
CONTENTS/xi
7.2 Geographical distribution, 104
7.3 The causal organisms and their habitat, 104
7.4 Clinical manifestations, 105
7.5 Differential diagnosis, 105
7.6 Essential investigations and their interpretation, 105
7.7 Management, 106
8 Keratomycosis, 107
8.1 Definition, 107
8.2 Geographical distribution, 107
8.3 The causal organisms and their habitat, 107
8.4 Clinical manifestations, 108
8.5 Essential investigations and their interpretation, 108
8.6 Management, 109
9 Otomycosis, 111
9.1 Definition, 111
9.2 Geographical distribution, 111
9.3 The causal organisms and their habitat, 111
9.4 Clinical manifestations, 111
9.5 Differential diagnosis, 112
9.6 Essential investigations and their interpretation, 112
9.7 Management, 112
10 Aspergillosis, 113
10.1 Definition, 113
10.2 Geographical distribution, 113
10.3 The causal organisms and their habitat, 113
10.4 Clinical manifestations, 114
10.4.1 Allergic aspergillosis, 114
10.4.2 Fungus ball of the lung, 115
10.4.3 Chronic necrotizing aspergillosis of the
lung, 115
10.4.4 Acute invasive aspergillosis of the lung, 116
10.4.5 Tracheobronchitis and obstructing bronchial
aspergillosis, 117
10.4.6 Sinusitis, 117
10.4.7 Cerebral aspergillosis, 118
10.4.8 Ocular aspergillosis, 119
10.4.9 Endocarditis and myocarditis, 119
10.4.10 Osteomyelitis, 120
10.4.11 Cutaneous aspergillosis, 120
10.4.12 Other forms of aspergillosis, 121
10.5 Aspergillosis in special hosts, 121
10.5.1 Patients with AIDS, 121
10.6 Essential investigations and their interpretation, 122
10.6.1 Microscopy, 122
xii/CONTENTS
10.6.2 Culture, 123
10.6.3 Skin tests, 123
10.6.4 Serological tests, 123
10.7 Management, 124
10.7.1 Allergic aspergillosis, 124
10.7.2 Fungus ball of the lung, 125
10.7.3 Chronic necrotizing aspergillosis of the
lung, 125
10.7.4 Acute invasive aspergillosis of the lung, 125
10.7.5 Tracheobronchitis and obstructing bronchial
aspergillosis, 128
10.7.6 Sinusitis, 128
10.7.7 Cerebral aspergillosis, 129
10.7.8 Endophthalmitis, 129
10.7.9 Endocarditis, 129
10.7.10 Osteomyelitis, 129
10.7.11 Cutaneous aspergillosis, 130
11 Deep candidosis, 131
11.1 Definition, 131
11.2 Geographical distribution, 131
11.3 The causal organisms and their habitat, 131
11.4 Clinical manifestations, 132
11.4.1 Oesophagitis, 132
11.4.2 Gastrointestinal candidosis, 133
11.4.3 Pulmonary candidosis, 133
11.4.4 CNS candidosis, 133
11.4.5 Endocarditis, myocarditis, pericarditis and
other vascular infections, 134
11.4.6 Renal candidosis, 135
11.4.7 Lower urinary tract candidosis, 135
11.4.8 Peritonitis, 136
11 4.9 Intrauterine candidosis, 136
11.4.10 Osteomyelitis, arthritis and myositis, 136
11.4.11 Endophthalmitis, 137
11.4.12 Disseminated candidosis, 137
11.5 Candidosis in special hosts, 139
11.5.1 Low birth weight infants, 139
11.5.2 Drug abusers, 139
11.5.3 Patients with AIDS, 139
11.6 Essential investigations and their interpretation, 140
11.6.1 Microscopy, 140
11.6.2 Culture, 140
11.6.3 Serological tests, 141
11.7 Management, 142
11.7.1 Oesophagitis, 142
11.7.2 Meningitis, 143
CONTENTS/xiii
11.7.3 Endocarditis and vascular infection, 143
11.7.4 Renal candidosis, 144
11.7.5 Lower urinary tract candidosis, 144
11.7.6 Peritonitis, 144
11.7.7 Osteomyelitis and arthritis, 145
11.7.8 Endophthalmitis, 145
11.7.9 Acute disseminated candidosis and
candidaemia, 146
11.7.10 Chronic disseminated candidosis, 147
12 Cryptococcosis, 149
12.1 Definition, 149
12.2 Geographical distribution, 149
12.3 The causal organism and its habitat, 149
12.4 Clinical manifestations, 150
12.4.1 Pulmonary cryptococcosis, 150
12.4.2 Meningitis, 151
12.4.3 Cutaneous cryptococcosis, 152
12.4.4 Osteomyelitis, 152
12.4.5 Other forms of cryptococcosis, 153
12.5 Cryptococcosis in special hosts, 153
12.5.1 Patients with AIDS, 153
12.6 Essential investigations and their interpretation, 154
12.6.1 Microscopy, 154
12.6.2 Culture, 154
12.6.3 Serological tests, 154
12.7 Management, 156
12.7.1 Meningitis and disseminated infection, 156
12.7.2 Pulmonary cryptococcosis, 158
12.7.3 Cutaneous cryptococcosis, 159
13 Mucormycosis, 160
13.1 Definition, 160
13.2 Geographical distribution, 160
13.3 The causal organisms and their habitat, 160
13.4 Clinical manifestations, 161
13.4.1 Rhinocerebral mucormycosis, 161
13.4.2 Pulmonary mucormycosis, 162
13.4.3 Gastrointestinal mucormycosis, 162
13.4.4 Cutaneous mucormycosis, 163
13.4.5 Disseminated mucormycosis, 163
13.4.6 Other forms of mucormycosis, 164
13.5 Differential diagnosis, 164
13.6 Essential investigations and their interpretation, 164
13.6.1 Microscopy, 164
13.6.2 Culture, 164
13.6.3 Serological tests, 164
xiv/CONTENTS
13.7 Management, 165
14 Blastomycosis, 167
14.1 Definition, 167
14.2 Geographical distribution, 167
14.3 The causal organism and its habitat, 167
14.4 Clinical manifestations, 167
14.4.1 Pulmonary blastomycosis, 168
14.4.2 Cutaneous blastomycosis, 168
14.4.3 Osteoarticular blastomycosis, 168
14.4.4 Genitourinary blastomycosis, 169
14.4.5 Other forms of disseminated
blastomycosis, 169
14.5 Blastomycosis in special hosts, 169
14.6 Differential diagnosis, 170
14.7 Essential investigations and their interpretation, 170
14.7.1 Microscopy, 170
14.7.2 Culture, 170
14.7.3 Serological tests, 171
14.8 Management, 171
15 Coccidioidomycosis, 172
15.1 Definition, 172
15.2 Geographical distribution, 172
15.3 The causal organism and its habitat, 172
15.4 Clinical manifestations, 173
15.4.1 Primary pulmonary coccidioidomycosis, 173
15.4.2 Chronic pulmonary coccidioidomycosis, 173
15.4.3 Disseminated coccidioidomycosis, 174
15.5 Coccidioidomycosis in special hosts, 175
15.5.1 Patients with AIDS, 175
15.6 Differential diagnosis, 176
15.7 Essential investigations and their interpretation, 176
15.7.1 Microscopy, 176
15.7.2 Culture, 177
15.7.3 Skin tests, 177
15.7.4 Serological tests, 177
15.8 Management, 178
15.8.1 Primary pulmonary coccidioidomycosis, 178
15.8.2 Chronic pulmonary coccidioidomycosis, 179
15.8.3 Disseminated coccidioidomycosis, 180
15.8.4 Meningitis, 180
16 Histoplasmosis, 182
16.1 Definition, 182
16.2 Geographical distribution, 182
16.3 The causal organism and its habitat, 182
CONTENTS/xv
16.4 Clinical manifestations, 183
16.4.1 Acute pulmonary histoplasmosis, 183
16.4.2 Chronic pulmonary histoplasmosis, 184
16.4.3 Disseminated histoplasmosis, 185
16.4.4 African histoplasmosis, 186
16.5 Histoplasmosis in special hosts, 186
16.5.1 Patients with AIDS, 186
16.6 Differential diagnosis, 187
16.7 Essential investigations and their interpretation, 187
16.7.1 Microscopy, 187
16.7.2 Culture, 188
16.7.3 Skin tests, 188
16.7.4 Serological tests, 188
16.8 Management, 189
16.8.1 Acute pulmonary histoplasmosis, 189
16.8.2 Chronic pulmonary histoplasmosis, 189
16.8.3 Disseminated histoplasmosis, 190
17 Paracoccidioidomycosis, 191
17.1 Definition, 191
17.2 Geographical distribution, 191
17.3 The causal organism and its habitat, 191
17.4 Clinical manifestations, 191
17.4.1 Chronic pulmonary
paracoccidioidomycosis, 192
17.4.2 Mucocutaneous paracoccidioidomycosis, 192
17.4.3 Other forms of disseminated
paracoccidioidomycosis, 193
17.5 Differential diagnosis, 193
17.6 Essential investigations and their interpretation, 193
17.6.1 Microscopy, 193
17.6.2 Culture, 193
17.6.3 Serological tests, 194
17.7 Management, 194
18 Chromoblastomycosis, 195
18.1 Definition, 195
18.2 Geographical distribution, 195
18.3 The causal organisms and their habitat, 195
18.4 Clinical manifestations, 195
18.5 Differential diagnosis, 196
18.6 Essential investigations and their interpretation, 196
18.6.1 Microscopy, 196
18.6.2 Culture, 197
18.7 Management, 197
XV1/CONTENTS
19 Entomophthoramycoses, 198
19.1 Rhinofacial conidiobolomycosis, 198
19.1.1 Definition, 198
19.1.2 Geographical distribution, 198
19.1.3 The causal organism and its habitat, 198
19.1.4 Clinical manifestations, 198
19.1.5 Differential diagnosis, 199
19.1.6 Essential investigations and their
interpretation, 199
19.1.7 Management, 199
19.2 Basidiobolomycosis, 199
19.2.1 Definition, 199
19.2.2 Geographical distribution, 199
19.2.3 The causal organism and its habitat, 200
19.2.4 Clinical manifestations, 200
19.2.5 Differential diagnosis, 200
19.2.6 Essential investigations and their
interpretation, 200
19.2.7 Management, 200
20 Lobomycosis, 202
20.1 Definition, 202
20.2 Geographical distribution, 202
20.3 The causal organism and its habitat, 202
20.4 Clinical manifestations, 202
20.5 Differential diagnosis, 203
20.6 Essential investigations and their interpretation, 203
20.6.1 Microscopy, 203
20.6.2 Culture, 203
20.7 Management, 203
21 Mycetoma, 204
21.1 Definition, 204
21.2 Geographical distribution, 204
j] the Causal organisms and their habitat, 204
^1.4 Clinical manifestations, 205
21.5 Differential diagnosis, 207
21.6 Essential investigations and their interpretation, 207
^16.1 Gross examination, 207
21.6.2 Microscopy, 207
21.6.3 Culture, 208
21.7 Management, 208
22 Rhinosporidiosis, 210
22.1 Definition, 210
22.2 Geographical distribution, 210
23 ™e Causal organism and its habitat, 210
CONTENTS/xvii
22.4 Clinical manifestations, 210
22.5 Differential diagnosis, 211
22.6 Essential investigations and their interpretation, 211
22.6.1 Microscopy, 211
22.6.2 Culture, 211
22.7 Management, 211
23 Sporotrichosis, 212
23.1 Definition, 212
23.2 Geographical distribution, 212
23.3 The causal organism and its habitat, 212
23.4 Clinical manifestations, 212
23.4.1 Cutaneous sporotrichosis, 213
23.4.2 Extracutaneous sporotrichosis, 213
23.5 Differential diagnosis, 214
23.6 Essential investigations and their interpretation, 215
23.6.1 Microscopy, 215
23.6.2 Culture, 215
23.6.3 Serological tests, 215
23.7 Management, 215
24 Hyalohyphomycosis, 217
24.1 Definition, 217
24.2 Fusarium infection, 217
24.2.1 Geographical distribution, 217
24.2.2 The causal organisms and their habitat, 217
24.2.3 Clinical manifestations, 217
24.2.4 Essential investigations and their
interpretation, 218
24.2.5 Management, 219
24.3 Scedospohum infection, 220
24.3.1 Geographical distribution, 220
24.3.2 The causal organisms and their habitat, 220
24.3.3 Clinical manifestations, 220
24.3.4 Essential investigations and their
interpretation, 221
24.3.5 Management, 221
24.4 Other agents of hyalohyphomycosis, 222
25 Penicillium marneffei infection, 223
25.1 Definition, 223
25.2 Geographical distribution, 223
25.3 The causal organism and its habitat, 223
25.4 Clinical manifestations, 224
25.5 Differential diagnosis, 224
25.6 Essential investigations and their interpretation, 225
25.6.1 Microscopy, 225
xviii/CONTENTS
25.6.2 Culture, 225
25.7 Management, 225
26 Phaeohyphomycosis, 227
26.1 Definition, 227
26.2 Geographical distribution, 227
26.3 The causal organisms and their habitat, 227
26.4 Clinical manifestations, 228
26.4.1 Subcutaneous phaeohyphomycosis, 228
26.4.2 Paranasal sinus infection, 228
26 A3 Cerebral phaeohyphomycosis, 229
26.4.4 Cutaneous infection, 229
26.4.5 Other forms of phaeohyphomycosis, 229
26.5 Differential diagnosis, 230
26.6 Essential investigations and their interpretation, 230
26.6.1 Microscopy, 230
26.6.2 Culture, 230
26.7 Management, 231
26.7.1 Subcutaneous phaeohyphomycosis, 231
26.7.2 Paranasal sinus infection, 231
26.7.3 Cerebral phaeohyphomycosis, 231
26.7.4 Cutaneous infection, 231
26.7.5 Other forms of phaeohyphomycosis, 231
27 Uncommon yeast infections, 232
27.1 Introduction, 232
27.2 Trichosporonosis, 232
27.2.1 Geographical distribution, 232
27.2.2 The causal organisms and their habitat, 232
27.2.3 Clinical manifestations, 232
27.2.4 Essential investigations and their
interpretation, 233
27.2.5 Management, 234
27.3 Systemic Malassezia infection, 234
27.3.1 Geographical distribution, 234
27.3.2 The causal organism and its habitat, 235
27.3.3 Clinical manifestations, 235
27.3.4 Essential investigations and their
interpretation, 235
27.3.5 Management, 236
Select bibliography, 237
Index, 241
|
| any_adam_object | 1 |
| author | Richardson, Malcolm D. Warnock, David W. |
| author_GND | (DE-588)139003142 (DE-588)172443059 |
| author_facet | Richardson, Malcolm D. Warnock, David W. |
| author_role | aut aut |
| author_sort | Richardson, Malcolm D. |
| author_variant | m d r md mdr d w w dw dww |
| building | Verbundindex |
| bvnumber | BV011840525 |
| callnumber-first | R - Medicine |
| callnumber-label | RC117 |
| callnumber-raw | RC117 |
| callnumber-search | RC117 |
| callnumber-sort | RC 3117 |
| callnumber-subject | RC - Internal Medicine |
| ctrlnum | (OCoLC)36430944 (DE-599)BVBBV011840525 |
| dewey-full | 616.9/69 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.9/69 |
| dewey-search | 616.9/69 |
| dewey-sort | 3616.9 269 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| edition | 2. ed. |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01825nam a2200481 c 4500</leader><controlfield tag="001">BV011840525</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20160429 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">980319s1997 |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0865427240</subfield><subfield code="9">0-86542-724-0</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)36430944</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV011840525</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-19</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC117</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.9/69</subfield><subfield code="2">21</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Richardson, Malcolm D.</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)139003142</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Fungal infection</subfield><subfield code="b">diagnosis and management</subfield><subfield code="c">Malcolm D. Richardson ; David W. Warnock</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">2. ed.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Oxford [u.a.]</subfield><subfield code="b">Blackwell Science</subfield><subfield code="c">1997</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XXI, 249 S.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Mycoses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Mycoses</subfield><subfield code="x">diagnosis</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Mycoses</subfield><subfield code="x">therapy</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Therapie</subfield><subfield code="0">(DE-588)4059798-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Mykose</subfield><subfield code="0">(DE-588)4075152-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Diagnose</subfield><subfield code="0">(DE-588)4012040-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Mykose</subfield><subfield code="0">(DE-588)4075152-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Diagnose</subfield><subfield code="0">(DE-588)4012040-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="8">1\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Mykose</subfield><subfield code="0">(DE-588)4075152-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Therapie</subfield><subfield code="0">(DE-588)4059798-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="8">2\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Warnock, David W.</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)172443059</subfield><subfield code="4">aut</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">HBZ Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=007996428&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-007996428</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">2\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield></record></collection> |
| id | DE-604.BV011840525 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-09T18:16:35Z |
| institution | BVB |
| isbn | 0865427240 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-007996428 |
| oclc_num | 36430944 |
| open_access_boolean | |
| owner | DE-19 DE-BY-UBM |
| owner_facet | DE-19 DE-BY-UBM |
| physical | XXI, 249 S. |
| publishDate | 1997 |
| publishDateSearch | 1997 |
| publishDateSort | 1997 |
| publisher | Blackwell Science |
| record_format | marc |
| spelling | Richardson, Malcolm D. Verfasser (DE-588)139003142 aut Fungal infection diagnosis and management Malcolm D. Richardson ; David W. Warnock 2. ed. Oxford [u.a.] Blackwell Science 1997 XXI, 249 S. txt rdacontent n rdamedia nc rdacarrier Mycoses Mycoses diagnosis Mycoses therapy Therapie (DE-588)4059798-2 gnd rswk-swf Mykose (DE-588)4075152-1 gnd rswk-swf Diagnose (DE-588)4012040-5 gnd rswk-swf Mykose (DE-588)4075152-1 s Diagnose (DE-588)4012040-5 s 1\p DE-604 Therapie (DE-588)4059798-2 s 2\p DE-604 Warnock, David W. Verfasser (DE-588)172443059 aut HBZ Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=007996428&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis 1\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk 2\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk |
| spellingShingle | Richardson, Malcolm D. Warnock, David W. Fungal infection diagnosis and management Mycoses Mycoses diagnosis Mycoses therapy Therapie (DE-588)4059798-2 gnd Mykose (DE-588)4075152-1 gnd Diagnose (DE-588)4012040-5 gnd |
| subject_GND | (DE-588)4059798-2 (DE-588)4075152-1 (DE-588)4012040-5 |
| title | Fungal infection diagnosis and management |
| title_auth | Fungal infection diagnosis and management |
| title_exact_search | Fungal infection diagnosis and management |
| title_full | Fungal infection diagnosis and management Malcolm D. Richardson ; David W. Warnock |
| title_fullStr | Fungal infection diagnosis and management Malcolm D. Richardson ; David W. Warnock |
| title_full_unstemmed | Fungal infection diagnosis and management Malcolm D. Richardson ; David W. Warnock |
| title_short | Fungal infection |
| title_sort | fungal infection diagnosis and management |
| title_sub | diagnosis and management |
| topic | Mycoses Mycoses diagnosis Mycoses therapy Therapie (DE-588)4059798-2 gnd Mykose (DE-588)4075152-1 gnd Diagnose (DE-588)4012040-5 gnd |
| topic_facet | Mycoses Mycoses diagnosis Mycoses therapy Therapie Mykose Diagnose |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=007996428&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| work_keys_str_mv | AT richardsonmalcolmd fungalinfectiondiagnosisandmanagement AT warnockdavidw fungalinfectiondiagnosisandmanagement |